Effective use of electroconvulsive therapy in late-life depression

Canadian Journal of Psychiatry

Volumn 47, Issue 8, 2002, Pages 734-741

  Flint, Alastair J ^a   Gagnon, Nadine ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Aged; Continuation treatment; Depressive disorder; Efficacy; Electroconvulsive therapy; Relapse; Side effects

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; COGNITION; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; NEUROLOGIC DISEASE; RELAPSE; REVIEW; SEIZURE THRESHOLD; TREATMENT OUTCOME;

EID: 0036808860     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204700804     Document Type: Review

References (59)

1. Sackeim HA. Use of electroconvulsive therapy in late-life depression. In: Schneider LS, Reynolds CF III, Lebowtiz BD, Friedhoff AJ, editors. Diagnosis and Treatment of Depression in Late Life. Washington (DC): American Psychiatric Press; 1994. p 259-77.
2. Olfson M, Marcus S, Sackeim HA, Thompson J, Pincus HA. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry 1998;155:22-9.
3. Flint AJ. Psychopharmacological management of the medically ill older patient. In: Melding PS, Draper B, editors. Geriatric Consultation Liaison Psychiatry. Oxford: Oxford University Press; 2001. p 267-94.
4. McCall WV, Cohen W, Reboussin B, Lawton P. Pretreatment differences in specific symptoms and quality of life among depressed inpatients who do and do not receive electroconvulsive therapy: A hypothesis regarding why the elderly are more likely to receive ECT. J ECT 1999;15:193-201.
5. Flint AJ, Rifat SL. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 1998;13:23-8.
6. Brodaty H, Luscombe G, Parker G, Wilhelm K, Hickie I, Austin M-P, and others. Increased rate of psychosis and psychomotor change in depression with age. Psychol Med 1997;27:1205-13.
7. Kroessler D. Relative efficacy rates for therapies of delusional depression. Convulsive Therapy 1985;1:173-82.
8. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, and others. ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. J ECT 2001;17:244-53.
9. Finlay-Jones R, Parker G. A consensus conference on psychotic depression. Aust NZ J Psychiatry 1993;27:581-9.
10. Wilkinson AW, Anderson DN, Peters S. Age and the effects of ECT. Int J Geriatr Psychiatry 1993;8:401-6.
11. O'Connor MK, Knapp R, Husain M, Rummans TA, Petrides G, Smith G, and others. The influence of age on the response of major depression to electroconvulsive therapy. A C.O.R.E. report. Am J Geriatr Psychiatry 2001;9:382-90.
12. Tew JD, Mulsant BH, Haskett RF, Prudic J, Thase ME, Crowe RR, and others. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999;156:1865-70.
13. Fink M, Bailine S, Petrides G. Electrode placement and electroconvulsive therapy: A search for the chimera. Arch Gen Psychiatry 2001;58:607-8.
14. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, and others. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Eng J Med 1993;328:839-46.
15. Sackeim HA, Prudic J, Devanand DP, NobleMS, Lisanby SH, Peyser S, and others. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-34.
16. Letemendia FJJ, Delva NJ, Rodenburg M, Lawson JS, Inglis J, Waldron JJ, and others. Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med 1993;23:349-60.
17. McCall WV, Reboussin DM, Weiner RD, Sackeim HA. Titrated moderately suprathreshold vs. fixed high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 2000;57:438-44.
18. Boylan LS, Haskett RF, Mulsant BH, Greenterg RM, Prudic J, Spicknall K, and others. Determinants of seizure threshold in ECT: Benzodiazepine use, anesthetic dosage, and other factors. J ECT 2000;16:3-18.
19. Krystal AD, Dean MD, Weiner RD, Tramontozzi LA, Connor KM, Lindahl VH, and others. ECT stimulus intensity: Are present ECT devices too limited? Am J Psychiatry 2000;157:963-7.
20. Lawson JS, Inglis J, Delva NJ, Rodenburg M, Waldron JJ, Letemendia FJJ. Electrode placement in ECT: Cognitive effects. Psychol Med 1990;20:335-44.
21. Bailine SH, Rifkin A, Kayne E, Selzer JA, Vital-Herne J, Blieka M, and others. Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry 2000;157:121-3.
22. Frukacz A, Mitchell P. Fitting the treatment lo the patient: Recent advances in the practice of electroconvulsive therapy. Aust N Z J Psychiatry 1995;29::484-91.
23. Petrides G, Fink M. The "half-age" stimulation strategy for ECT dosing. Convulsive Therapy 1996;12:138-46.
24. Beale MD, Kellner CH, Pritchett JT, Bernstein HJ, Bums CM, Knapp R. Stimulus dose-titration in ECT: A 2-year clinical experience. Convulsive Therapy 1994;10:171-6.
25. Sackeim H, Decina P, Prohovnik I, Malitz S. Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry 1987;44:355-60.
26. Chung KF, Wong SJ. Stimulus dose titration for electroconvulsive therapy. Psychiatry and Clinical Neurosciences 2001;55:105-10.
27. Heikman P, Tuunainen A, Kuoppasalmi K. Value of the initial stimulus dose in right unilateral and bifrontal electroconvulsive therapy. Psychol Med 1999;29:1417-23.
28. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991;14:803-43.
29. Krystal AD, Coffey CE, Weiner RD, Holsinger T. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. J Neuropsychiatry Clin Neurosci 1998;10:178-86.
30. Scott AIF, Boddy H. The effect of repeated bilateral electroconvulsive therapy on seizure threshold. J ECT 2000;16:244-51
31. Tew JD, Mulsant BH, Towers A. ECT in older patients with physical illness. In: Melding PS, Draper B, editors. Geriatric Consultation Liaison Psychiatry. Oxford: Oxford University Press; 2001. p 295-314.
32. Shapira B, Tubi N, Lerer B. Balancing speed of response to ECT in major depression and adverse cognitive effects: Role of treatment schedule. J ECT 2000;16:97-109.
33. Abrams R. The mortality rate with ECT. Convulsive Therapy 1997;13:125-7.
34. Burd J, Kettl P. Incidence of asystole in electroconvulsive therapy in elderly patients. Am J Geriatr Psychiatry 1998;6:203-11.
35. Castelli I, Steiner LA, Kaufmann MA, Alfill PH, Schouten R, Welch CA, and others. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg 1995;80:557-61.
36. Avramov MN, Stool LA, White PF, Husain MM. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy. J Clin Anesth 1998;10:394-400.
37. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993;150:904-9.
38. Rice EH, Sombrotto LB, Markowitz JC, Leon AC. Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry 1994;151:1637-41.
39. Tomac TA, Rummans TA, Pileggi TS, Li H. Safety and efficacy of electroconvulsive therapy in patients over age 85. Am J Geriatr Psychiatry 1997;5:126-30.
40. Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 2001;46:710-9.
41. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. 2nd Ed. Washington (DC): American Psychiatric Press; 2001.
42. NIH Consensus Development Panel. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018-24.
43. Zervas IM, Calev A, Jandorf L, Schwartz J, Gaudino E, Tubi N, and others. Age-dependent effects of electroconvulsive therapy on memory. Convulsive Therapy 1993;9:39-42.
44. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry 2000;15:729-35.
45. Moellentine C, Rummans T, Ahlskog JE, Harmsen WS, Suman VJ, O'Connor MK, and others. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 1998;10:187-93.
46. Figiel GS, Coffey CE, Djang WT, Hoffman G Jr, Doraiswamy PM. Brain magnetic resonance imaging findings in ECT-induced delirium. J Neuropsychiatry Clin Neurosci 1990;2:53-8.
47. Aronson TA, Shukla S, Gujavarty K, Hoff A, DiBuono M, Khan E. Relapse in delusional depression: A retrospective study of the course of treatment. Compr Psychiatry 1988;29:12-21.
48. Godber C, Rosenvinge H, Wilkinson D, Smithies J. Depression in old age: Prognosis after ECT. Int J Geriatr Psychiatry 1987;2:19-24.
49. Flint AJ, Rifat SL. Two-year outcome of psychotic depression in late life. Am J Psychiatry 1998;155:178-83.
50. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, and others. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. A randomized controlled trial. JAMA 2001;285:1299-307.
51. Rabheru K, Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 1997;42:476-84.
52. Mcdonald WM, Phillips VL, Figiel GS, Marsteller FA, Simpson CD, Bailey MC. Cost-effective maintenance treatment of resistant geriatric depression. Psychiatr Ann 1998;28:47-52.
53. Gagné GG, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 2000;157:1960-5.
54. Seager CP, Bird RL. Imipramine with electrical treatment in depression - A controlled trial. Journal of Mental Science 1962;108:704-7.
55. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1965;4:438-42.
56. Kay DW, Fahy T, Garside RF. A 7-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 1970;117:667-71.
57. Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrström J, Black C, and others. Relapse prevention by means ofparoxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996;94:241-51.
58. Mayur PM, Gangadhar BN, Subbakrishna DK, Janakiramaiah N. Discontinuation of antidepressant drugs during electroconvulsive therapy: A controlled study. J Affect Disord 2000;58:37-41.
59. Meyers BS, Klimstra SA, Gabriele M, Hamilton M, Kakuma T, Tirumalasetti F, and others. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 2001;9:415-22.